Name
thyroid_med
Label
Thyroid Medication: Self-reported use
Description

Self-reported drugs at PSG visit, open text then grouped according to effect

Domain
takingornot
  • 0: Not taking
  • 1: Taking
Type
choices
Thyroid Medication: Self-reported use vs Study visit number
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Incident Outcomes Tracking
Total 1,123 758 566 121 2 -
Not taking 1,026 668 490 108 1 -
Taking 97 90 76 13 1 -
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 1
Male Female Total
Total 608 515 1,123
Not taking 579 447 1,026
Taking 29 68 97
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 2
Male Female Total
Total 406 352 758
Not taking 377 291 668
Taking 29 61 90
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 3
Male Female Total
Total 304 262 566
Not taking 280 210 490
Taking 24 52 76
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 4
Male Female Total
Total 67 54 121
Not taking 64 44 108
Taking 3 10 13
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 5
Male Female Total
Total - 2 2
Not taking - 1 1
Taking - 1 1
Thyroid Medication: Self-reported use vs Race of the participant
Visit 1
Asian Black Hispanic Native American White Total
Total 12 23 13 10 1,065 1,123
Not taking 10 20 12 10 974 1,026
Taking 2 3 1 - 91 97
Thyroid Medication: Self-reported use vs Race of the participant
Visit 2
Asian Black Hispanic Native American White Total
Total 4 8 6 6 734 758
Not taking 4 7 5 6 646 668
Taking - 1 1 - 88 90
Thyroid Medication: Self-reported use vs Race of the participant
Visit 3
Asian Black Hispanic Native American White Total
Total 4 4 5 4 549 566
Not taking 4 3 4 4 475 490
Taking - 1 1 - 74 76
Thyroid Medication: Self-reported use vs Race of the participant
Visit 4
Asian Black Hispanic Native American White Total
Total 3 1 2 2 113 121
Not taking 3 1 2 2 100 108
Taking - - - - 13 13
Thyroid Medication: Self-reported use vs Race of the participant
Visit 5
Asian Black Hispanic Native American White Total
Total - - - - 2 2
Not taking - - - - 1 1
Taking - - - - 1 1